Table 2 Multiple antibiotic resistance in ambulatory-onset urine Enterobacterales isolates (2011–2020)
ESBL resistance profile | n | Resistance to additional antimicrobials n (%) | |||
|---|---|---|---|---|---|
FQ | TMP/SMX | NFT | Beta-lactams | ||
ESBL only | 145,448 (100%) | 101,971 (70.1%) | 87,145 (59.9%) | 48,470 (33.5%) | 134,038 (92.2%) |
ESBL + FQ | 101,971 (100%) | 73,363 (71.9%) | 38,372 (37.6%) | 101,222 (99.3%) | |
ESBL + TMP/SMX | 87,145 (100%) | 73,363 (84.2%) | 35,619 (40.9%) | 86,738 (99.5%) | |
ESBL + NFT | 48,740 (100%) | 38,372 (78.7%) | 35,619 (73.1%) | 48,497 (99.5%) | |
ESBL + FQ + TMP/SMX | 73,363 (100%) | 30,784 (42.0%) | 73,030 (99.5%) | ||
ESBL + FQ + TMP/SMX + NFT | 30,784 (100%) | 30,698 (99.7%) | |||